Comparison of the permeability of RdRp inhibitors, remdesivir, molnupiravir and azvudine, in placental barrier cell models and exploration of their transport mechanisms.

GS-441524 - Copycat Sci

Lagevrio (molnupiravir) - Ridgeback Biotherap, Merck (MSD)

azvudine (FNC) - Granlen

remdesivir - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42497385

Dan Liu; Kundan Zhu; Mengru Bai; Mingyang Chen; Qian Shen; Shuixian Zhang; Wei Zhang; Yong Wu

Jul 25, 2026